For decades, surgical aortic valve replacement (SAVR) has been the standard treatment for
severe aortic stenosis (AS). With the clinical introduction of the concept of transcatheter …

Twelve years after the first transcatheter aortic valve implantation (TAVI) for severe aortic
stenosis (AS), European and American guidelines, as well as the FDA, indicated that TAVI is …

The introduction of transcatheter aortic valve implantation (TAVI) has revolutionised the
treatment of patients with symptomatic severe aortic valve stenosis (AS). In extreme and high …

Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment
for high and intermediate-risk patients with severe aortic stenosis (AS). Recent studies have …

In the last decade, transcatheter aortic valve implantation (TAVI), a disruptive technology,
has revolutionized the therapy of symptomatic severe aortic stenosis, and current guidelines …

Aims: Although transcatheter aortic valve implantation (TAVI) is officially indicated for severe
aortic stenosis (AS) patients at intermediate or higher surgical risk, the procedure is now …

Transcatheter aortic valve implantation (TAVI) is currently indicated for patients with severe
symptomatic aortic stenosis who are unfit for surgery or when the surgical risk is high …

Background Transcatheter aortic valve implantation (TAVI) has been established as a
reasonable alternative to surgical aortic valve replacement (SAVR) in patients with severe …

The introduction of percutaneous treatment of severe aortic stenosis with transcatheter aortic
valve implantation (TAVI) remains one of the greatest achievements of interventional …

Background Transcatheter aortic valve replacement (TAVR) was initially introduced to treat
patients with aortic valve stenosis (AS) at high-risk for surgical aortic valve replacement …